retatrutide 1mg UK Guide: Key Facts on the New Weight-Loss Drug Retatrutide Research Peptide | GLP3-R

The combined inflammatory effects cause vascular endothelial cells to activate pro-angiogenic factors including vascular endothelial growth factor (VEGF)

Clinical trials of semaglutide show that gastrointestinal side effectsincluding diarrheaoccur in about 2025% of participants, but the majority resolve within the first month

doi: 10.1038/oby.2002.150 [DOI] [PubMed] [Google Scholar] 35

This follows a pattern thats been building for a while: the GLP-1 receptor is present in the brain, not just in the gut and pancreas

When that happens, fatigue, constipation, dizziness, hair shedding, nutrient gaps, and muscle loss risk may increase

Both substances affect digestion and blood sugar, and separating them allows your body to process each independently without added strain